Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion

被引:30
|
作者
Margolis, Elyssa B. [1 ]
Karkhanis, Anushree N. [2 ]
机构
[1] Univ Calif San Francisco, Dept Neurol, Alcohol & Addict Res Grp, 675 Nelson Rising Lane,Box 0444, San Francisco, CA 94143 USA
[2] SUNY Binghamton, Dept Psychol, Dev Exposure Alcohol Res Ctr, Ctr Dev & Behav Neurosci, 4400 Vestal Pkwy East, Binghamton, NY 13902 USA
基金
美国国家卫生研究院;
关键词
VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS SHELL; PLACE PREFERENCE PARADIGM; SOCIAL DEFEAT STRESS; SELECTIVE ACTIVATION; CATECHOLAMINE INNERVATION; PRESYNAPTIC INHIBITION; BASOLATERAL AMYGDALA; LATERAL HABENULA; MEASURING REWARD;
D O I
10.1016/j.neuint.2019.104504
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neural circuits that enable an organism to protect itself by promoting escape from immediate threat and avoidance of future injury are conceptualized to carry an "aversive" signal. One of the key molecular elements of these circuits is the kappa opioid receptor (KOR) and its endogenous peptide agonist, dynorphin. In many cases, the aversive response to an experimental manipulation can be eliminated by selective blockade of KOR function, indicating its necessity in transmitting this signal. The dopamine system, through its contributions to reinforcement learning, is also involved in processing of aversive stimuli, and KOR control of dopamine in the context of aversive behavioral states has been intensely studied. In this review, we have discussed the multiple ways in which the KORs regulate dopamine dynamics with a central focus on dopamine neurons and projections from the ventral tegmental area. At the neuronal level, KOR agonists inhibit dopamine neurons both in the somatodendritic region as well as at terminal release sites, through various signaling pathways and ion channels, and these effects are specific to different synaptic sites. While the dominant hypotheses are that aversive states are driven by decreases in dopamine and increases in dynorphin, reported exceptions to these patterns indicate these ideas require refinement. This is critical given that KOR is being considered as a target for development of new therapeutics for anxiety, depression, pain, and other psychiatric disorders.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Kappa opioid receptor and oligodendrocyte remyelination
    Wang, Fei
    Mei, Feng
    OPIOID HORMONES, 2019, 111 : 281 - 297
  • [32] Molecular modeling on kappa opioid receptor and its interaction with nonpeptide kappa opioid agonists
    刘东祥
    蒋华良
    沈敬山
    朱维良
    赵磊
    陈凯先
    嵇汝运
    ActaPharmacologicaSinica, 1999, (02) : 36 - 41
  • [33] Prediction of 3D structure for the kappa opioid receptor and novel kappa opioid receptor selective ligands
    Kim, Soo-Kyung
    Goddard, William A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [34] Medullary kappa-opioid receptor neurons inhibit pain and itch through a descending circuit
    Nguyen, Eileen
    Smith, Kelly M.
    Cramer, Nathan
    Holland, Ruby A.
    Bleimeister, Isabel H.
    Flores-Felix, Krystal
    Silberberg, Hanna
    Keller, Asaf
    Le Pichon, Claire E.
    Ross, Sarah E.
    BRAIN, 2022, 145 (07) : 2586 - 2601
  • [35] Molecular modeling on kappa opioid receptor and its interaction with nonpeptide kappa opioid agonists
    Liu, DX
    Jiang, HL
    Shen, JS
    Zhu, WL
    Zhao, L
    Chen, KX
    Ji, RY
    ACTA PHARMACOLOGICA SINICA, 1999, 20 (02): : 131 - 136
  • [36] NEUROCHEMICAL EVIDENCE THAT ESTROGEN-INDUCED SUPPRESSION OF KAPPA-OPIOID-RECEPTOR-MEDIATED REGULATION OF TUBEROINFUNDIBULAR DOPAMINERGIC-NEURONS IS PROLACTIN-INDEPENDENT
    WAGNER, EJ
    MANZANARES, J
    MOORE, KE
    LOOKINGLAND, KJ
    NEUROENDOCRINOLOGY, 1994, 59 (03) : 197 - 201
  • [37] Enhanced kappa-opioid receptor-mediated analgesia by antisense targeting the sigma(1) receptor
    King, M
    Pan, YX
    Mei, JF
    Chang, A
    Xu, J
    Pasternak, GW
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 331 (01) : R5 - R6
  • [39] Orphan receptor or kappa(3)-opioid receptor? Reply
    Pasternak, GW
    Standifer, KM
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1996, 17 (06) : 217 - 218
  • [40] Antidepressant-like Effects of Buprenorphine are Primarily Mediated Through the Kappa Opioid Receptor
    Falcon, Edgardo
    Lucki, Irwin
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S540 - S541